Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro
about
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expressionInsulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Insulin-like growth factor-1 stimulation of lymphopoiesisInsulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination.Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).Lymphocyte recruitment to the lung.Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis.Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells.Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.Insulin-like growth factor-1 prevents Abeta[25-35]/(H2O2)- induced apoptosis in lymphocytes by reciprocal NF-kappaB activation and p53 inhibition via PI3K-dependent pathway.Insulin-like growth factor I in inclusion-body myositis and human muscle cultures.Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment
P2860
Q24563012-C32F6592-161F-402A-8C75-B9A108696CDFQ33890792-5BF8A35F-17E3-42D1-8985-0ADD6711295CQ34169714-9AD4292C-0D81-4FC5-B629-C26D2DDAEF7EQ34201336-3BC2CA37-0EBF-46B3-9DBB-076ED5BED084Q35829445-F0B951E8-214E-4634-837D-E25043FA2B01Q37381231-A1513FE0-B58C-4840-B4AA-6205D7614801Q37940798-4AE534A4-AFBD-48AE-9191-467C9E111889Q41124612-1F207095-B2B6-4868-9BFA-D0382DA92572Q41706345-9B3328F8-4975-44F9-9738-CAC05EFC8973Q42013443-D6888BF6-AE15-4ACD-80B7-9681C6B510A1Q46879861-429688E5-B521-4B7C-9317-468D7C303A76Q47292492-013BA779-7B39-4DD5-A7BF-A3380C05B6CEQ50762545-04F49FFC-A73F-4B61-B8A7-2EC46FF31D62Q56974053-B2B5B547-CCD8-433B-AE1A-4CEFDED5C448
P2860
Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Structural and functional char ...... -like growth factor I in vitro
@ast
Structural and functional char ...... -like growth factor I in vitro
@en
Structural and functional char ...... -like growth factor I in vitro
@nl
type
label
Structural and functional char ...... -like growth factor I in vitro
@ast
Structural and functional char ...... -like growth factor I in vitro
@en
Structural and functional char ...... -like growth factor I in vitro
@nl
prefLabel
Structural and functional char ...... -like growth factor I in vitro
@ast
Structural and functional char ...... -like growth factor I in vitro
@en
Structural and functional char ...... -like growth factor I in vitro
@nl
P2093
P2860
P356
P1476
Structural and functional char ...... -like growth factor I in vitro
@en
P2093
D M Center
J S Berman
M Boni-Schnetzler
V F Tapson
P2860
P304
P356
10.1172/JCI113703
P407
P577
1988-09-01T00:00:00Z